Overview

Nexplanon Removal: Subcutaneous vs. Topical Lidocaine

Status:
Recruiting
Trial end date:
2023-05-31
Target enrollment:
0
Participant gender:
Female
Summary
A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure and time to removal.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Augusta University
Treatments:
Lidocaine
Lidocaine, Prilocaine Drug Combination
Prilocaine
Criteria
Inclusion Criteria:

- Females with Nexplanon implant in place, desiring removal No allergy to lidocaine or
any component of EMLA cream Age greater than or equal to 18years English as primary
language Not pregnant

Exclusion Criteria:

- pregnant non-emglish speaking age less than 18 yo Allergy to lidocaine or EMLA